Osaic Holdings
RYTM icon

Osaic Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

Osaic Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
982
+43
+5% +$3.89K ﹤0.01% 4879
2026
Q1 		$81.7K Sell
939
-100
-10% -$9.72K ﹤0.01% 4833
2025
Q4 		$111K Buy
1,039
+59
+6% +$6.26K ﹤0.01% 4620
2025
Q3 		$99.7K Buy
980
+1
+0.1% +$93 ﹤0.01% 4781
2025
Q2 		$61.9K Buy
979
+389
+66% +$23.8K ﹤0.01% 4895
2025
Q1 		$31.3K Sell
590
-83
-12% -$4.61K ﹤0.01% 5045
2024
Q4 		$37.7K Buy
673
+5
+0.7% +$276 ﹤0.01% 4904
2024
Q3 		$35K Sell
668
-492
-42% -$23.6K ﹤0.01% 5001
2024
Q2 		$47.6K Buy
1,160
+432
+59% +$17.2K ﹤0.01% 4719
2024
Q1 		$31.5K Buy
728
+519
+248% +$22.7K ﹤0.01% 5068
2023
Q4 		$9.61K Hold
209
– – ﹤0.01% 5853
2023
Q3 		$4.79K Sell
209
-40
-16% -$896 ﹤0.01% 6292
2023
Q2 		$4.11K Buy
249
+40
+19% +$722 ﹤0.01% 6398
2023
Q1 		$3.73K Hold
209
– – ﹤0.01% 6476
2022
Q4 		$6K Hold
209
– – ﹤0.01% 6216
2022
Q3 		$5K Sell
209
-1
-0.5% -$19 ﹤0.01% 6386
2022
Q2 		$1K Hold
210
– – ﹤0.01% 7140
2022
Q1 		$2K Hold
210
– – ﹤0.01% 6909
2021
Q4 		$2K Sell
210
-600
-74% -$6.74K ﹤0.01% 7048
2021
Q3 		$11K Sell
810
-105
-11% -$1.6K ﹤0.01% 6156
2021
Q2 		$18K Sell
915
-80
-8% -$1.66K ﹤0.01% 5730
2021
Q1 		$21K Buy
995
+45
+5% +$1.3K ﹤0.01% 5441
2020
Q4 		$28K Buy
950
+75
+9% +$1.91K ﹤0.01% 4955
2020
Q3 		$19K Buy
875
+675
+338% +$15.5K ﹤0.01% 4948
2020
Q2 		$4K Hold
200
– – ﹤0.01% 5585
2020
Q1 		$3K Buy
+200
New +$3.58K ﹤0.01% 5569

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Osaic Holdings's RYTM Position: Q2 2026 in Review

Osaic Holdings increased its Rhythm Pharmaceuticals (RYTM) stake by 4.6% in Q2 2026, buying an estimated $3.89K and bringing the position to 982 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #4879.

Osaic Holdings first reported a position in RYTM in Q1 2020 and has held it in 26 quarters since. The position peaked at $111K in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Osaic Holdings held 982 shares of Rhythm Pharmaceuticals worth $109K as of Q2 2026.
  • Osaic Holdings bought 43 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $3.89K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4879 holding.
  • Osaic Holdings first reported a position in Rhythm Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Rhythm Pharmaceuticals position peaked at $111K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.